MEDIGEN VACCINE BIOLOGICS CORPORATE financial statements, including revenue, expenses, profit, and loss
The total revenue of 6547 for the last quarter is 171.34 M TWD, and it's 21.51% lower compared to the previous quarter. The net income of Q4 23 is -582.13 M TWD.